ArticleBMC health services research2026
Impact of centralized volume-based procurement of high-value medical consumables on patients' hospitalization expenses in Gansu, China: an interrupted time series analysis.
Article in BMC health services research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHigh prices of medical consumables pose a major barrier for patients. To address those inflated prices, the National Healthcare Security Administration of China implemented the Centralized Volume-Based Procurement policy (CVBP) in 2021. However, evidence assessing the effect of CVBP in Gansu is insufficient. This study aims to estimate the impact of CVBP for high-value medical consumables in Gansu on the hospitalization expenses.
methodsData from 8076 inpatients in Gansu who underwent surgeries involving coronary stents, artificial joints, or intraocular lenses between April 2019 and October 2024 were collected. An interrupted time series analysis (ITSA) was conducted to examine the effect of CVBP on patient hospitalization expenses. An autoregressive integrated moving average (ARIMA) model was used to assess the difference between the predicted and actual expenses after the implementation of CVBP.
results(i) After implementation, the material expense per patient who underwent surgeries involving artificial joints was reduced by 387.782 Chinese yuan (CNY) (95%CI: −592.583 to −182.981, p < 0.001) per capita per month. The material expense of patients decreased immediately by 18,668.870 CNY (95%CI: −24,241.620 to −13,096.120, p < 0.001) per capita in the month when CVBP for coronary stents was implemented. The expense changes for intraocular lenses were not statistically significant. In addition, an immediate upward trend of 0.022 CNY per capita per month (95%CI: −0.017 to 0.026, p < 0.05) after the implementation of CVBP in terms of the percentage of anesthesia expenses was observed in the post-intervention month. (ii) The results of the ARIMA predictions indicated that per capita material expense savings at months post-CVBP were 14,028.187 CNY for coronary stents, 24,476.634 CNY for artificial joints and 280.039 CNY for intraocular lenses.
conclusionsThe implementation of the CVBP of high-value medical consumables saved patient hospitalization expenses and material expenses in Gansu, China. Future research should analyze the long-term effects of CVBP on medical insurance funds and total health expenses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.